EVANGELISTA, LAURA
 Distribuzione geografica
Continente #
AS - Asia 4.460
NA - Nord America 3.438
SA - Sud America 1.284
EU - Europa 505
AF - Africa 97
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.804
Nazione #
US - Stati Uniti d'America 3.315
SG - Singapore 3.165
BR - Brasile 1.115
CN - Cina 671
VN - Vietnam 193
DE - Germania 112
HK - Hong Kong 89
IT - Italia 73
AR - Argentina 64
IN - India 64
GB - Regno Unito 59
BD - Bangladesh 57
CA - Canada 53
EC - Ecuador 42
MX - Messico 38
RU - Federazione Russa 38
ZA - Sudafrica 35
PL - Polonia 33
TR - Turchia 30
IQ - Iraq 28
NL - Olanda 24
ES - Italia 22
MA - Marocco 20
AT - Austria 17
CO - Colombia 16
FR - Francia 16
PK - Pakistan 16
FI - Finlandia 14
ID - Indonesia 14
JP - Giappone 14
SE - Svezia 14
UA - Ucraina 14
AE - Emirati Arabi Uniti 13
CZ - Repubblica Ceca 13
IE - Irlanda 13
VE - Venezuela 13
SA - Arabia Saudita 12
PE - Perù 11
AU - Australia 10
AZ - Azerbaigian 10
KE - Kenya 10
IL - Israele 9
UZ - Uzbekistan 9
CL - Cile 8
LT - Lituania 8
JO - Giordania 7
KG - Kirghizistan 7
TN - Tunisia 7
AL - Albania 6
NG - Nigeria 6
NP - Nepal 6
OM - Oman 6
PY - Paraguay 6
TW - Taiwan 6
DZ - Algeria 5
JM - Giamaica 5
PH - Filippine 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
EG - Egitto 4
HN - Honduras 4
IR - Iran 4
KW - Kuwait 4
LV - Lettonia 4
UY - Uruguay 4
BH - Bahrain 3
BW - Botswana 3
DK - Danimarca 3
GE - Georgia 3
GT - Guatemala 3
KZ - Kazakistan 3
NR - Nauru 3
PT - Portogallo 3
RO - Romania 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BE - Belgio 2
CR - Costa Rica 2
DM - Dominica 2
ET - Etiopia 2
GA - Gabon 2
KH - Cambogia 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
SN - Senegal 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AM - Armenia 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
Totale 9.791
Città #
Singapore 1.002
Dallas 875
The Dalles 844
Shanghai 422
Ashburn 311
Beijing 135
São Paulo 102
Hong Kong 88
Los Angeles 74
Ho Chi Minh City 70
Seattle 70
New York 52
Santa Clara 44
Council Bluffs 42
Boardman 41
Hanoi 40
Brooklyn 30
Chandler 29
Munich 29
Warsaw 28
Curitiba 24
Rio de Janeiro 24
Wilmington 23
Montreal 22
Boston 20
Chicago 20
Brasília 19
Campinas 17
Johannesburg 17
Assago 16
Chennai 16
Goiânia 16
Toronto 16
Belo Horizonte 15
Dhaka 15
Guayaquil 15
Milan 14
Phoenix 14
Quito 14
San Mateo 14
Ann Arbor 13
Atlanta 13
Helsinki 13
Stockholm 13
Baghdad 12
Charlotte 12
Dublin 12
Porto Alegre 12
Salvador 12
San Francisco 12
Tokyo 12
Guarulhos 11
Ribeirão Preto 11
Baku 10
Brno 10
Buenos Aires 10
Düsseldorf 10
London 10
Reston 10
Santo André 10
Amsterdam 9
Biên Hòa 9
Cape Town 9
Caxias do Sul 9
Mexico City 9
New Delhi 9
Ankara 8
Blumenau 8
Fortaleza 8
Istanbul 8
Montes Claros 8
Nuremberg 8
Orem 8
Riyadh 8
Bishkek 7
Dubai 7
Haiphong 7
Joinville 7
Lima 7
Nairobi 7
Recife 7
San Jose 7
Sorocaba 7
Sumaré 7
Tashkent 7
Vienna 7
Amman 6
Belém 6
Delhi 6
Denver 6
Duque de Caxias 6
Houston 6
Itaquaquecetuba 6
Lauterbourg 6
Manchester 6
Maricá 6
Mauá 6
Praia Grande 6
Agadir 5
Anápolis 5
Totale 5.191
Nome #
10-Year Clinical Experience with 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients 494
18F-fluorodeoxyglucose PET/computed tomography and risk stratification after neoadjuvant treatment in esophageal cancer patients 98
BNCT treatment: 18F-FBPA PET-CT 86
A prospective trial for the evaluation of esophageal cancer patients: FDG PET/CT vs. c.e.CT vs. FDG PET/c.e.CT 79
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer 69
An incidental pancreatic finding at 18F-choline PET/CT: Chronic mass-forming pancreatitis 66
SEGMENTAL FDG-PET/CT IN SOLITARY PULMONARY NODULE: PRELIMINARY DATA OF THE PET ITALIAN TRIAL 66
18F-FET PET/CT in Calcifying Pseudoneoplasm of the Neuraxis: First Case 47
Development and evaluation of a bayesian optimization FDG population-based input function for implementing parametric imaging in the clinical practice 46
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports 45
18F-Choline PET/CT: An Alternative Tracer for Hodgkin Lymphoma? 45
Positron emission tomography/computed tomography and esophageal cancer in the clinical practice: How does it affect the prognosis? 45
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting 43
18F-choline PET/CT in prostate cancer for the staging, the restaging and planning radiotherapy treatment 43
Advancing Prostate Cancer Care: Prostate-specific Membrane Antigen–based Radioligand Therapy at the Forefront 42
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 42
Diagnosi e stadiazione del cancro della mammella Il Medico Nucleare: stato dell’arte e risposta ai punti controversi 41
18F-Choline: Prostate Cancer18F-choline PET/CT: an increasing role in cancer evaluation 41
Comparison between conventional imaging (CI) and wholebody 18F-choline (FCH) positron emission tomography/ computed tomography (PET/CT) in patients (pts) with prostate cancer (PCa) 40
18 F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases 40
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 40
18F-FDG PET/CT in gynecologic malignancies: single Institution experience 40
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy 39
18F-FDG or 68Ga/18F-PSMA PET/CT in recurrent renal cancer? 39
18F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature 39
Relazione tra ischemia miocardica inducibile e livelli plasmatici di proteina C reattiva in pazienti con sospetta cardiopatia ischemica 39
Non-palpable Pulmonary Nodules and Uniportal-VATS: Radio-guided Localization (ROLL) Experience of a Lung Multidisciplinary Team 38
18F-Fluoroestradiol Positron Emission Tomography In Breast Cancer Patients: Systematic Review Of The Literature &; Meta-Analysis 37
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 37
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach 37
MUNES: a MUltidisciplinar Neutron Source for BNCT and Nuclear Waste characterization 37
ENDOCRINE ORGANS INVOLVEMENT IN BREAST CANCER: WHEN THE TEAMWORK MAKES THE DIFFERENCE 36
18F-Choline PET/CT and prostatic gland/fossae recurrence: what can help to identify the local recurrence of disease? 36
L’imaging funzionale nelle disautonomie 35
18F-FDG PET/CT in ovarian cancer 35
18F-DOPA PET/CT in different neuroendocrine settings: staging, restaging and increase in tumor markers 35
New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy 34
18F-FDG PET/MRI in adult sarcomas 34
[18F]FDG and Lymphomas: Still a Winning Golden Couple in the Era of FAPI-Based Radiotracers 33
Il radiologo e il medico nucleare: nodulo/i polmonare/i 33
Emerging Radiopharmaceuticals in Pet Imaging for Mesothelioma: A Review of [18F]FDG Alternatives 33
An Evaluation of the Diagnostic Accuracy of [68Ga]Ga-PSMA-11 vs. [18F]F-PSMA-1007 PET/CT for Lymph Node Staging in Patient Candidates for Radical Prostatectomy and Lymph Node Dissection: A Single Institutional Analysis 33
Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study 33
The role of 18f-fdg pet/ct in staging and prognostication of mantle cell lymphoma: An italian multicentric study 32
18F-Fluoroestradiol positron emission tomography in breast cancer patients: systematic review of the literature & meta-analysis 32
Prostate MRI and PSMA-PET in the Primary Diagnosis of Prostate Cancer 32
Comparison of prognostic value of baseline and nitrate Single-photon Emission computed tomography imaging in patients with ischaemic left ventricular dysfunction 31
Relation between stress-induced myocardial ischemia and C- reactive protein levels in patients with suspected coronary arteery disease 31
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review– part 2 30
Clinical Application of PET/MRI 30
Il nodulo polmonare e la PET/CT: i ‘se’ e i ‘quando’ 30
Incidental Detection of Sarcomatoid Lung Cancer by [18F] Choline Positron Emission Tomography/Computed Tomography 29
Ruolo della PET/scintigrafia ossea? 29
Ruolo della PET nella malattia oligometastatica 29
Head-to-head comparison between 18F-FDG PET/CT and PET/MRI in breast cancer 29
Boron Neutron Capture Therapy 29
Will68Ga PSMA-radioligands be the only choice for nuclear medicine in prostate cancer in the near future? A clinical update 29
Prognostic value of myocardial perfusion scintigraphy in elderly patients with hypertension: a 10-year follow-up analysis 29
The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer 28
Usefullness of stress cardiac single photon emission computesd tomography iomaging late after percutaneous coronary intervention for assessing cardiac events and time to such events 28
Additional Value of PET and CT Image-Based Features in the Detection of Occult Lymph Node Metastases in Lung Cancer: A Systematic Review of the Literature 28
PET-Imaging molecolare con traccianti innovativiCaratterizzazione clinica e molecolare mini-invasiva del tumore della mammella localmente avanzato 28
Physiological joint pitfall and misinterpration of PET/CT DOPA Scan 28
Prevalence of post-stress myocardial stunning by gated- SPECT in diabetic patients: results and prospective multi-center trial 28
Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review 28
Boron neutron capture therapy and 18F-labelled borophenylalanine positron emission tomography: a critical and clinical overview of the literature 27
PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction 27
Role of FDG-PET/CT in the staging of colonrectal cancer 27
Guidelines for bone metastases in prostate cancer 27
Ruolo della Tomografia ad emissione di fotone singolo nella determinazione del rischio cardiovascolare nei pazienti diabetici: risultati di un trial prospettico, multicentrico 27
The impact of PET imaging on triple negative breast cancer: an updated evidence-based perspective 27
Accuracy of 18F-FDG PET/CT versus bone marrow biopsy in assessing bone marrow involvement in paediatric Hodgkin's Lymphoma. Accuracy in a multicenter series of 156 patients 27
Interpretative reproducibility of cardiac stress imaging: direct comparison between dobutamine echocardiography and single photon emission computed tomography 27
[18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases 27
Tumour marker guided Positron Emission Tomography in Breast Cancer patients: A recipe for a perfect wedding. A systematic literature review & meta-analysis 27
Is There a Role for FAPI PET in Urological Cancers? 27
Other than restaging phase: Serial FCH PET/CTscans can predict the response to chemotherapy in castrate-resistant prostate cancer? 27
The effects of androgen deprivation therapy on the 18F-choline uptake in prostate cancer patients undergoing neoadjuvant treatment 27
Ruolo della Tomografia ad emissione di fotone singolo nella definizione della probabilità di cardiopatia ischemica nei pazienti diabetici: risultati di un trial multi prospettico, multicentrico 26
Effects of the High Definition technology on Standardized Uptake Values (SUVs) obtained by Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) 26
Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art 26
Diagnostic Applications of Nuclear Medicine: Prostatic Cancer 26
Targeted therapy with Radium-223 of bone metastases 26
Bone metastases from prostate cancer: Biology, diagnosis and management 26
Clinical Impact of 18F-FDG PET/CT in the Diagnostic Workup of Pancreatic Ductal Adenocarcinoma: A Systematic Review 26
The bone pathway: 223Ra-dichloride 26
64CuCl2 PET/CT in a hyperfunctioning parathyroid gland 26
Risk stratification and prognostic assessment by myocardial perfusion-gated SPECT in patients with left bundle-branch block and low-intermediate cardiac risk 26
Nuovi traccianti tiroidei PET 26
An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases 26
Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer 26
FDG PET/MRI in the follow-up of hepatocellular carcinoma after liver transplantation 26
Could the serial determination of Ca15.3 serum improve the diagnostic accuracy of PET/CT? Results from small population with previous breast cancer 26
Additional value of pet radiomic features for the initial staging of prostate cancer: A systematic review from the literature 25
Comparison between18F-Dopa and 18F-Fet PET/CT in patients with suspicious recurrent high grade glioma: A literature review and our experience 25
Relation between wall thickening on gated perfusion SPECT and functional recovery after coronary revascularization in patients with previous myocardial infarction 25
In memoriam: Marion Hendriks-de Jong 25
Role of SPECT imaging in the definition of cardiac risk in daibetic patients without history of coronary artery disease: results of a prospective, multi-center trials 25
Tumour Markers and Molecular Imaging with FDG PET/CT in Breast Cancer: Their Combination for Improving the Prediction of Disease Relapse, Positron Emission Tomography 25
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors 25
Totale 3.913
Categoria #
all - tutte 76.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.129


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 18 5 7 11 6 0 6
2021/202229 1 0 1 8 1 2 1 1 4 2 6 2
2022/202375 12 5 8 12 3 5 0 3 14 5 8 0
2023/20241.128 2 5 9 4 1 10 3 4 377 59 282 372
2024/20254.366 119 153 19 77 50 505 226 206 878 1.137 480 516
2025/20264.574 1.633 682 874 848 419 118 0 0 0 0 0 0
Totale 10.227